This fact sheet provides clinicians with information on safety strategies and considerations related to the discontinuation of Protaphane® InnoLet® in Australia.

This fact sheet has been developed to provide information about discontinuation of multiple insulin products in Australia. The fact sheet aims to assist consumers, their families and/or carers understand the discontinuation of multiple insulin products and the impact it has on the health care they receive.

This guidance document provides clinicians with information on safety strategies and considerations related to the discontinuation of multiple insulin products in Australia.

This issue includes items on measurement for improvement, climate, medication safety, diagnosis, technology, well being, and more.

Also covered are the latest from The Joint Commission Journal on Quality and Patient Safety, Clinical Communiqué, Emergency Medicine Australasia,  BMJ Quality & Safety, and International Journal for Quality in Health Care. 

The Commission is seeking a full-time, non-ongoing EL1 Senior Project Officer, Clinical Care Standards.

The position advertised is for a full-time vacancy. A merit pool is intended to be created for similar future full-time/part-time vacancies.

Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Daylight Time (AEDT) 9 February 2025.

Questions about the role can be directed to Alice Bhasale (02) 7232 5124.

This issue includes items on health literacy, medication safety, variation, burnout, diagnosis, osteoporosis, and more. 

Also covered are the latest from The Joint Commission Journal on Quality and Patient Safety, Journal of Patient Safety, Pediatric Quality & &Safety, Australian Journal of Primary Health, BMJ Leader, BMJ Quality & Safety, International Journal for Quality in Health Care, JBI Evidence Synthesis, Health Affairs, Health Affairs Scholar care Quarterly, and the UK’s NICE and the USA’s AHRQ.